{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:29:34Z","timestamp":1788881374750,"version":"build-2803163510"},"reference-count":124,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007113","name":"Arak University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007113","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.vaccine.2020.10.016","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T09:11:18Z","timestamp":1602234678000},"page":"7612-7628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-0147","authenticated-orcid":false,"given":"Ashkan","family":"Safavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0616-8870","authenticated-orcid":false,"given":"Amirhosein","family":"Kefayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Mahdevar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3021-6147","authenticated-orcid":false,"given":"Ardavan","family":"Abiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7244-6066","authenticated-orcid":false,"given":"Fatemeh","family":"Ghahremani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.10.016_b0005","doi-asserted-by":"crossref","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2148-9-52","article-title":"Differential stepwise evolution of SARS coronavirus functional proteins in different host species","volume":"9","author":"Tang","year":"2009","journal-title":"BMC Evol Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.016_b0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/21645515.2019.1670035","article-title":"Computational tools for modern vaccine development","volume":"16","author":"Sunita","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.016_b0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/20477724.2018.1446773","article-title":"Current progress of immunoinformatics approach harnessed for cellular-and antibody-dependent vaccine design","volume":"112","author":"Kazi","year":"2018","journal-title":"Pathog Glob Health"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.016_b0025","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/ciy595","article-title":"Immune responses to Middle East respiratory syndrome coronavirus during the acute and convalescent phases of human infection","volume":"68","author":"Shin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.10.016_b0030","first-page":"410","article-title":"Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis","volume":"19","author":"Ortega","year":"2020","journal-title":"EXCLI J"},{"issue":"8","key":"10.1016\/j.vaccine.2020.10.016_b0035","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2147\/DDDT.S67861","article-title":"Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach","volume":"21","author":"Oany","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.vaccine.2020.10.016_b0040","doi-asserted-by":"crossref","unstructured":"Kumar, S.J., Drug and vaccine design against Novel Coronavirus (2019-nCoV) spike protein through Computational approach. 2020.","DOI":"10.20944\/preprints202002.0071.v1"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0045","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12967-019-2116-8","article-title":"Epitope\u2010based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study","volume":"17","author":"Ul Qamar","year":"2019","journal-title":"J Transl Med2019"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.016_b0050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/v12030254","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2020.10.016_b0055","doi-asserted-by":"crossref","unstructured":"Watanabe, Y., et al., Exploitation of glycosylation in enveloped virus pathobiology. BBA-GEN SUBJECTS 2019.1863(10),1480-1497.","DOI":"10.1016\/j.bbagen.2019.05.012"},{"key":"10.1016\/j.vaccine.2020.10.016_b0060","article-title":"Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass","author":"Zhang","year":"2020","journal-title":"Spectrometry."},{"issue":"Apr;88(Pt 4):","key":"10.1016\/j.vaccine.2020.10.016_b0065","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1099\/vir.0.82587-0","article-title":"Cross-reactive antibody responses to nsp1 and nsp2 of Porcine reproductive and respiratory syndrome virus","author":"Johnson","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.10.016_b0070","doi-asserted-by":"crossref","unstructured":"Khailany, R.A., M. Safdar, and M.J.G.r. Ozaslan, Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020 Jun;19:100682. doi: 10.1016\/j.genrep.2020.100682. Epub 2020 Apr 16.","DOI":"10.1016\/j.genrep.2020.100682"},{"key":"10.1016\/j.vaccine.2020.10.016_b0075","first-page":"18.19.1","article-title":"TepiTool: a pipeline for computational prediction of T cell epitope candidates","volume":"1114","author":"Paul","year":"2016","journal-title":"Curr Protoc Immunol"},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2020.10.016_b0080","doi-asserted-by":"crossref","first-page":"D854","DOI":"10.1093\/nar\/gkp1004","article-title":"The immune epitope database 2.0","volume":"38","author":"Vita","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2020.10.016_b0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jtbi.2014.01.018","article-title":"A novel multi-epitope peptide vaccine against cancer: an in silico approach","volume":"349","author":"Nezafat","year":"2014","journal-title":"J Theor Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.016_b0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1093-3263(03)00160-8","article-title":"Quantitative online prediction of peptide binding to the major histocompatibility complex.","volume":"22","author":"Hattotuwagama","year":"2004","journal-title":"J MOL GRAPH MODEL"},{"issue":"19","key":"10.1016\/j.vaccine.2020.10.016_b0095","doi-asserted-by":"crossref","first-page":"16472","DOI":"10.1021\/am5044592","article-title":"Massive electrical conductivity enhancement of multilayer graphene\/polystyrene composites using a nonconductive filler","volume":"6","author":"Chakraborty","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.vaccine.2020.10.016_b0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-10-296","article-title":"NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction","volume":"1810","author":"Nielsen","year":"2009","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-8-238","article-title":"Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method","volume":"8","author":"Nielsen","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.016_b0110","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"Jensen","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2020.10.016_b0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jtbi.2015.04.026","article-title":"In silico analyses of Wilms\u05f3 tumor protein to designing a novel multi-epitope DNA vaccine against cancer","volume":"379","author":"Khalili","year":"2015","journal-title":"J Theor Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.016_b0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00251-010-0441-4","article-title":"NetCTLpan: pan-specific MHC class I pathway epitope predictions","volume":"62","author":"Stranzl","year":"2010","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0125","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41598-018-19456-1","article-title":"Novel Immunoinformatics Approaches to Design Multi-epitope Subunit Vaccine for Malaria by Investigating Anopheles Salivary Protein","volume":"8","author":"Pandey","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1471-2105-8-424","article-title":"Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction","volume":"8","author":"Larsen","year":"2007","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2020.10.016_b0135","doi-asserted-by":"crossref","unstructured":"Lo, Y.-S., C.-Y. Lin, and J.-M.J.N.a.r. Yang, PCFamily: a web server for searching homologous protein complexes. Nucleic Acids Res. 2010 Jul;38(Web Server issue):W516-22. doi: 10.1093\/nar\/gkq464. Epub 2010 May 28.","DOI":"10.1093\/nar\/gkq464"},{"key":"10.1016\/j.vaccine.2020.10.016_b0140","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3389\/fimmu.2018.01369","article-title":"Predicting HLA CD4 immunogenicity in human populations","volume":"9","author":"Dhanda","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Function,, and Bioinformatics, Prediction of continuous B\u2010cell epitopes in an antigen using recurrent neural network","volume":"165","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.vaccine.2020.10.016_b0150","series-title":"International Conference on Artificial Immune Systems","article-title":"BcePred: prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties","author":"Saha","year":"2004"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0155","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinformatics."},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-34254-5","article-title":"Exploring NS3\/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches","volume":"8","author":"Ikram","year":"2018","journal-title":"Sci. Rep"},{"key":"10.1016\/j.vaccine.2020.10.016_b0165","first-page":"531531","article-title":"Protein identification and analysis tools on the ExPASy server","volume":"112","author":"Gasteiger","year":"1999","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2020.10.016_b0170","doi-asserted-by":"crossref","unstructured":"Pritam, M., et al., A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria. Int J Biol Macromol 2020. 1;158:159-179. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.04.191.","DOI":"10.1016\/j.ijbiomac.2020.04.191"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.016_b0175","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.vaccine.2017.12.001","article-title":"Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine","volume":"36","author":"Kaba","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.10.016_b0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.molimm.2019.05.016","article-title":"Epitope-based immunoinformatics study of a novel Hla-MntC-SACOL0723 fusion protein from Staphylococcus aureus: Induction of multi-pattern immune responses","volume":"114","author":"Ahmadi","year":"2019","journal-title":"Mol Immunol ."},{"key":"10.1016\/j.vaccine.2020.10.016_b0185","doi-asserted-by":"crossref","unstructured":"Safavi, A., et al., Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model. Hum Vaccin Immunother. 2020 Jun 4;1-13. https:\/\/doi.org\/10.1080\/21645515.2020.1763693.","DOI":"10.1080\/21645515.2020.1763693"},{"key":"10.1016\/j.vaccine.2020.10.016_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074506","article-title":"The VHSE-based prediction of proteasomal cleavage sites","volume":"8","author":"Xie","year":"2013","journal-title":"Plos One"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.10.016_b0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00251-005-0781-7","article-title":"The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage","volume":"57","author":"Nielsen","year":"2005","journal-title":"Immunogenetics"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.016_b0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.6026\/97320630013231","article-title":"Short peptide epitope design from hantaviruses causing HFRS","volume":"13","author":"Sankar","year":"2017","journal-title":"Bioinformation"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1875035400801010022","article-title":"Bioinformatic approach for identifying parasite and fungal candidate subunit vaccines","volume":"1","author":"Doytchinova","year":"2008","journal-title":"The Open Vaccine Journal"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.016_b0210","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.ygeno.2018.10.007","article-title":"Secret-AAR: a web server to assess the antigenic density of proteins and homology search against bacterial and parasite secretome proteins","volume":"111","author":"Cornejo-Granados","year":"2019","journal-title":"Genomics"},{"issue":"23","key":"10.1016\/j.vaccine.2020.10.016_b0215","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","article-title":"High-throughput prediction of protein antigenicity using protein microarray data","volume":"26","author":"Magnan","year":"2010","journal-title":"Bioinformatics ."},{"key":"10.1016\/j.vaccine.2020.10.016_b0220","first-page":"709216","article-title":"Genome-wide prediction of vaccine candidates for Leishmania major: an integrated approach","author":"Singh","year":"2015","journal-title":"Journal of Tropical Medicine"},{"issue":"17","key":"10.1016\/j.vaccine.2020.10.016_b0225","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1093\/bioinformatics\/btz029","article-title":"AllerCatPro\u2014prediction of protein allergenicity potential from the protein sequence","volume":"35","author":"Maurer-Stroh","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2020.10.016_b0230","article-title":"Immunoinformatics approach for epitope-based peptide vaccine design and active site prediction against polyprotein of emerging oropouche virus","volume":"6718083","author":"Adhikari","year":"2018","journal-title":"Journal of Immunologt Research"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.016_b0235","volume":"1","author":"Schrodinger","year":"2010","journal-title":"The PyMOL molecular graphics system."},{"issue":"14","key":"10.1016\/j.vaccine.2020.10.016_b0240","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1093\/bioinformatics\/btl222","article-title":"BaCelLo: a balanced subcellular localization predictor.","volume":"22","year":"2006","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.016_b0245","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1021\/pr900665y","article-title":"SherLoc2: a high-accuracy hybrid method for predicting subcellular localization of proteins","volume":"8","author":"Briesemeister","year":"2009","journal-title":"J. Proteome Res."},{"issue":"9","key":"10.1016\/j.vaccine.2020.10.016_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025746","article-title":"KAP degradation by calpain is associated with CK2 phosphorylation and provides a novel mechanism for cyclosporine A-induced proximal tubule injury","volume":"6","author":"Tornavaca","year":"2011","journal-title":"PLoS One."},{"issue":"13","key":"10.1016\/j.vaccine.2020.10.016_b0255","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1093\/nar\/gkg600","article-title":"SVM-Prot: web-based support vector machine software for functional classification of a protein from its primary sequence","volume":"31","author":"Cai","year":"2003","journal-title":"Nucleic Acids Res ."},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.016_b0260","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.str.2013.08.005","article-title":"High-resolution comparative modeling with RosettaCM","volume":"21","author":"Song","year":"2013","journal-title":"Structure"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.016_b0265","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat Protoc"},{"issue":"8","key":"10.1016\/j.vaccine.2020.10.016_b0270","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/nprot.2012.085","article-title":"Template-based protein structure modeling using the RaptorX web server","volume":"7","author":"K\u00e4llberg","year":"2012","journal-title":"Nat Protoc"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.016_b0275","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"issue":"S9","key":"10.1016\/j.vaccine.2020.10.016_b0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/prot.22540","article-title":"Structure prediction for CASP8 with all-atom refinement using Rosetta","volume":"77","author":"Raman","year":"2009","journal-title":"Proteins"},{"issue":"173","key":"10.1016\/j.vaccine.2020.10.016_b0290","article-title":"Defining and searching for structural motifs using DeepView\/Swiss-PdbViewer","volume":"13","author":"Johansson","year":"2012","journal-title":"BMC Bioinformatics."},{"issue":"S1","key":"10.1016\/j.vaccine.2020.10.016_b0295","first-page":"S162","volume":"30","author":"Guex","year":"2009","journal-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0300","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinf"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.016_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002829","article-title":"Reliable B cell epitope predictions: impacts of method development and improved benchmarking","volume":"8","author":"Kringelum","year":"2012","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.016_b0310","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/pmic.200300771","article-title":"Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence","volume":"4","author":"Blom","year":"2004","journal-title":"Proteomics"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.016_b0315","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/emboj.2013.79","article-title":"Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology","volume":"32","author":"Steentoft","year":"2013","journal-title":"The EMBO journal"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.016_b0320","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/prot.22555","article-title":"Identification, analysis, and prediction of protein ubiquitination sites","volume":"78","author":"Radivojac","year":"2010","journal-title":"Proteins Struct Funct Bioinf"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.016_b0325","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1006\/jmbi.1999.3310","article-title":"Sequence and structure-based prediction of eukaryotic protein phosphorylation sites1","volume":"294","author":"Blom","year":"1999","journal-title":"J Mol Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.016_b0330","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/prot.24403","article-title":"How good is automated protein docking?","volume":"81","author":"Kozakov","year":"2013","journal-title":"Proteins"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.10.016_b0335","doi-asserted-by":"crossref","first-page":"W96","DOI":"10.1093\/nar\/gkh354","article-title":"ClusPro: a fully automated algorithm for protein\u2013protein docking","volume":"32","author":"Comeau","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.016_b0340","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2013protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat Protoc ."},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.016_b0345","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/prot.21117","article-title":"an FFT\u2010based protein docking program with pairwise potentials","volume":"65","author":"Kozakov","year":"2006","journal-title":"Proteins"},{"issue":"31","key":"10.1016\/j.vaccine.2020.10.016_b0350","doi-asserted-by":"crossref","first-page":"21771","DOI":"10.1074\/jbc.M513041200","article-title":"Surfactant protein a directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response importance of supratrimeric oligomerization","volume":"281","author":"Yamada","year":"2006","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.016_b0355","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem."},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.016_b0360","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J Med Chem"},{"issue":"21","key":"10.1016\/j.vaccine.2020.10.016_b0365","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212 ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56463-2","article-title":"phenoxyethyl piperidine\/Morpholine Derivatives as pAS and cAS inhibitors of cholinesterases: insights for future Drug Design","volume":"9","author":"Pourshojaei","year":"2019","journal-title":"Sci. Rep"},{"issue":"278","key":"10.1016\/j.vaccine.2020.10.016_b0375","first-page":"278","article-title":"The immune epitope database and analysis resource in epitope discovery and synthetic vaccine design","volume":"8","author":"Fleri","year":"2017","journal-title":"Front Immunol"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.10.016_b0380","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.016_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2020.10.016_b0390","first-page":"1","article-title":"Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study","author":"Peele","year":"2020","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-55613-w","article-title":"Designing a multi-epitopic vaccine against the enterotoxigenic Bacteroides fragilis based on immunoinformatics approach","volume":"9","author":"Majid","year":"2019","journal-title":"Sci. Rep"},{"key":"10.1016\/j.vaccine.2020.10.016_b0400","doi-asserted-by":"crossref","unstructured":"Castiglione, F., et al., How the interval between prime and boost injection affects the immune response in a computational model of the immune system. Comput Math Methods Med. 2012;2012:842329. doi: 10.1155\/2012\/842329. Epub 2012 Sep 11.","DOI":"10.1155\/2012\/842329"},{"key":"10.1016\/j.vaccine.2020.10.016_b0405","doi-asserted-by":"crossref","first-page":"107259","DOI":"10.1016\/j.compbiolchem.2020.107259","article-title":"Designing of precise vaccine construct against visceral leishmaniasis through predicted epitope ensemble: a contemporary approach","author":"Singh","year":"2020","journal-title":"Comput Biol Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.016_b0410","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1747-0285.2012.01423.x","article-title":"Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine","volume":"80","author":"Wahome","year":"2012","journal-title":"Chem Biol Drug Des"},{"issue":"6797","key":"10.1016\/j.vaccine.2020.10.016_b0415","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35021239","article-title":"Vaccines against intracellular infections requiring cellular immunity","volume":"406","author":"Seder","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.10.016_b0420","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3389\/fimmu.2018.01716","article-title":"Predicting antigen presentation\u2014What could we learn from a million peptides?","volume":"9","author":"Gfeller","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.016_b0425","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.humimm.2015.11.012","article-title":"Major histocompatibility complex linked databases and prediction tools for designing vaccines","volume":"77","author":"Singh","year":"2016","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.016_b0430","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1586\/14760584.2014.907528","article-title":"Physicochemical and functional characterization of vaccine antigens and adjuvants","volume":"13","author":"Dey","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.016_b0435","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jps.10296","article-title":"Thermal stability of vaccines","volume":"92","author":"Brandau","year":"2003","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.016_b0440","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/bioinformatics\/btx662","article-title":"PaRSnIP: sequence-based protein solubility prediction using gradient boosting machine","volume":"34","author":"Rawi","year":"2018","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.016_b0445","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4161\/hv.4.3.5291","article-title":"Formulation and characterization of a ten-peptide single-vial vaccine EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy","volume":"4","author":"Beebe","year":"2008","journal-title":"Hum Vaccin"},{"issue":"13","key":"10.1016\/j.vaccine.2020.10.016_b0450","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1128\/AEM.05259-11","article-title":"Effect of chemical chaperones in improving the solubility of recombinant proteins in Escherichia coli","volume":"77","author":"Prasad","year":"2011","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0455","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1475-2859-10-60","article-title":"Post-production protein stability: trouble beyond the cell factory","volume":"10","author":"Vazquez","year":"2011","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.vaccine.2020.10.016_b0460","first-page":"157895","article-title":"Neutralization of virus infectivity by antibodies: old problems in new perspectives","author":"Klasse","year":"2014","journal-title":"Advances in Biology"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.016_b0465","doi-asserted-by":"crossref","first-page":"530","DOI":"10.6026\/97320630015530","article-title":"A combined view of B-cell epitope features in antigens","volume":"15","author":"Zobayer","year":"2019","journal-title":"Bioinformation"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.016_b0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144475","article-title":"Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in silico approach applied to emerging infectious diseases","volume":"10","author":"Shi","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.016_b0475","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s10989-018-9780-z","article-title":"In silico analysis of synaptonemal complex protein 1 (SYCP1) and acrosin binding protein (ACRBP) antigens to design novel multiepitope peptide cancer vaccine against","volume":"25","author":"Safavi","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.10.016_b0480","doi-asserted-by":"crossref","first-page":"W126","DOI":"10.1093\/nar\/gkm219","article-title":"OPTIMIZER: a web server for optimizing the codon usage of DNA sequences","volume":"35","author":"Puigbo","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2020.10.016_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105872","article-title":"Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine","volume":"76","author":"Safavi","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.016_b0490","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.016_b0495","first-page":"1493","article-title":"Immunization against Leishmania major infection in BALB\/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens","volume":"22","author":"Salehi-Sangani","year":"2019","journal-title":"Iran J Basic Med Sci."},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.016_b0500","doi-asserted-by":"crossref","first-page":"e0142548","DOI":"10.1371\/journal.pone.0142548","article-title":"Immunogenicity and protective efficacy of Brugia malayi heavy chain myosin as homologous DNA, protein and heterologous DNA\/protein prime boost vaccine in rodent model","volume":"10","author":"Gupta","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.016_b0505","first-page":"37","article-title":"High yield overexpression, refolding, purification and characterization of Pseudomonas aeruginosa type B-flagellin: an improved method without sonication","volume":"5","author":"Faezi","year":"2016","journal-title":"Int J Mol Cell Med"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.016_b0510","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3382\/ps\/pey475","article-title":"Efficacy of CpG-ODN and Freund\u2019s immune adjuvants on antibody responses induced by chicken infectious anemia virus VP1, VP2, and VP3 subunit proteins","volume":"98","author":"Fang","year":"2019","journal-title":"Poult. Sci. J."},{"key":"10.1016\/j.vaccine.2020.10.016_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103704","article-title":"Genome based screening of epitope ensemble vaccine candidates against dreadful visceral leishmaniasis using immunoinformatics approach","volume":"136","author":"Singh","year":"2019","journal-title":"Microb Pathog"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.016_b0520","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","article-title":"Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals","volume":"52","author":"Ni","year":"2020","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.016_b0525","first-page":"5370","article-title":"IgH chain class switch recombination: mechanism and regulation.J","volume":"193","author":"Stavnezer","year":"2014","journal-title":"Immunol"},{"key":"10.1016\/j.vaccine.2020.10.016_b0530","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijbiomac.2020.07.117","article-title":"A Candidate multi-epitope vaccine against SARS-CoV-2","volume":"164","author":"Ka","year":"2020","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.016_b0535","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMra1204186","article-title":"Designing tomorrow\u2019s vaccines","volume":"368","author":"Nabel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.10.016_b0540","first-page":"1","article-title":"Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study","volume":"just-accepted","author":"Enayatkhani","year":"2020","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.016_b0545","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.016_b0550","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/JVI.01716-09","article-title":"Dynamics of coronavirus replication-transcription complexes","volume":"84","author":"Hagemeijer","year":"2010","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.016_b0555","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.4049\/jimmunol.0804287","article-title":"Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.016_b0560","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nchembio.1403","article-title":"Adaptive immune activation: glycosylation does matter","volume":"9","author":"Wolfert","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"16","key":"10.1016\/j.vaccine.2020.10.016_b0565","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1128\/JVI.00080-16","article-title":"Homology-based identification of a mutation in the coronavirus RNA-dependent RNA polymerase that confers resistance to multiple mutagens","volume":"90","author":"Sexton","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.10.016_b0570","series-title":"Coronaviruses","first-page":"1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","author":"Fehr","year":"2015"},{"key":"10.1016\/j.vaccine.2020.10.016_b0575","unstructured":"Campbell, K.M., et al., Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles. 2020."},{"key":"10.1016\/j.vaccine.2020.10.016_b0580","doi-asserted-by":"crossref","unstructured":"Gangaev, A., et al., Profound CD8 T cell responses towards the SARS-CoV-2 ORF1ab in COVID-19 patients. 2020.","DOI":"10.21203\/rs.3.rs-33197\/v1"},{"issue":"188","key":"10.1016\/j.vaccine.2020.10.016_b0585","article-title":"The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease","volume":"11","author":"Garbuglia","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.10.016_b0590","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jbi.2014.11.003","article-title":"An overview of bioinformatics tools for epitope prediction: implications on vaccine development","volume":"53","author":"Soria-Guerra","year":"2015","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2020.10.016_b0595","doi-asserted-by":"crossref","unstructured":"Sarkar, B., et al., Immunoinformatics-guided designing of epitope-based subunit vaccine against the SARS Coronavirus-2 (SARS-CoV-2). Immunobiology 2020: 225 (3). 151955.","DOI":"10.1016\/j.imbio.2020.151955"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.016_b0600","first-page":"618","article-title":"Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2)","volume":"92","author":"Bhattacharya","year":"2020","journal-title":"Immunoinformatics approach"},{"key":"10.1016\/j.vaccine.2020.10.016_b0605","doi-asserted-by":"crossref","first-page":"100338","DOI":"10.1016\/j.imu.2020.100338","article-title":"Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach","volume":"19","author":"Joshi","year":"2020","journal-title":"Inform. Med. Unlocked"},{"key":"10.1016\/j.vaccine.2020.10.016_b0610","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2683286","article-title":"Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach","volume":"2020","author":"Abdelmageed","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.vaccine.2020.10.016_b0615","doi-asserted-by":"crossref","unstructured":"Huang, J.-D., B.-z. Zhang, and Y.-f.J.b. Hu, Mapping the Immunodominance Landscape of SARS-CoV-2 Spike Protein for the Design of Vaccines against COVID-19. 2020.","DOI":"10.1101\/2020.04.23.056853"},{"key":"10.1016\/j.vaccine.2020.10.016_b0620","series-title":"MAbs","article-title":"Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology","author":"Berry","year":"2010"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:56Z","timestamp":1759402076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20313074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":124,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0264410X20313074"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}